RANI Hisse Senedi Fiyat Grafiği
RANI Kazanmak
Rani Therapeutics Holdings Inc
$1.07
10.82%
$0.1
Kapanışta: May 11, 16:00:00 GMT-4
$1.08
0.93%
$0.01
Sonrası Piyasa: May 11, 20:00:00 GMT-4
Geri
Rani Therapeutics Holdings Inc (RANI) Kazanmak
Önemli İstatistikler
Önceki Kapanış
$0.9655
Açılış fiyatı
$0.9995
Günün Aralığı
$0.9901 - $1.11
52 haftalık aralık
$0.387 - $3.87
İşlem hacmi
2.3M
Ort.Hacim
1.0M
Dividend yield
--
EPS (TTM)
-0.59
Piyasa Değeri
$133.5M
RANI nedir?
Rani Therapeutics Holdings, Inc. engages in the operation of a clinical stage bio-therapeutics company. The company is headquartered in San Jose, California and currently employs 69 full-time employees. The company went IPO on 2021-07-30. The firm has developed the RaniPill capsule, which is a proprietary and patented platform technology, intended to replace subcutaneous injection or intravenous infusion of biologics and drugs with oral dosing. The RaniPill capsule is designed to deliver a variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. The company has two configurations of the platform: the RaniPill GO and the RaniPill HC. The RaniPill GO is designed to deliver up to a 3 mg dose of drug in microtablet form with high bioavailability. The company is also developing a high-capacity version of the RaniPill capsule known as the RaniPill HC. Its product candidate pipeline includes obesity programs (RT-114 and RT-116), immunology programs (RT-105 and RT-111) and endocrinology programs (RT-102 and RT-110).
